A comprehensive retrospective cohort analysis spanning nearly 20 years has identified a U-shaped association between serum lactate dehydrogenase (LDH) levels and all-cause mortality in cancer patients. Published in BMC Cancer, the findings suggest both low and high LDH concentrations correlate with increased mortality, emphasizing the nuanced role of this metabolic enzyme in cancer prognosis and potential implications for patient monitoring and therapy optimization.